Deutsche Bank Reiterates Hold Rating on Quest Diagnostics

According to a recent report, Deutsche Bank is reiterating a Hold rating on Quest Diagnostics DGX but see Risk/Reward rating in the near future. These indications are based on interaction with shareholders and a sense that changes at the top will result in a positive catalyst event. In the report, Deutsche Bank said, "While we remain hesitant to alter our investment opinion on DGX shares, we highlight the potential for the risk/reward equation to become more favorable in the context of bigger changes at DGX." DGX closed yesterday at $58.18.